Schneider P, Schirren J, Trainer C, Vogt-Moykopf I
Chirurgische Abteilung, Thoraxklinik, Heidelberg.
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:841-5.
Surgery is the treatment of choice in patients with non-small cell lung cancer stages I-IIIA. This is not restricted to younger patients, it may also be true for elderly ones. 6907 patients suffering bronchial carcinoma were analysed at the Thoraxklinik Heidelberg-Rohrbach (10/1984-12/1994). 2464 patients underwent resection of bronchial carcinoma. The age distribution was as follows: 0-64 years (n = 1734), 65-74 years (n = 662), 75-85 years (n = 67), older than 85 years (n = 1). Lobectomy was the most common type of resection for all patients. The frequency of pneumonectomy was lower in older patients, while the relative proportion of segmental resections was higher. The 30-day mortality was 6% for patients younger than 64 years and 10% for patients older than 65 years. For the latter group, the 5-year-survival probability was 44% for the combined p-stages I and II, and 19% for p-stage IIIA. In conclusion, the results indicate that, under the condition of a precise preoperative risk-to-benefit evaluation, surgical treatment of bronchial carcinoma is also indicated for elderly patients.
手术是 I - IIIA 期非小细胞肺癌患者的首选治疗方法。这并不局限于年轻患者，老年患者也可能如此。海德堡 - 罗尔巴赫胸科医院（1984 年 10 月 - 1994 年 12 月）分析了 6907 例支气管癌患者。2464 例患者接受了支气管癌切除术。年龄分布如下：0 - 64 岁（n = 1734），65 - 74 岁（n = 662），75 - 85 岁（n = 67），85 岁以上（n = 1）。肺叶切除术是所有患者最常见的切除类型。老年患者全肺切除术的频率较低，而节段性切除术的相对比例较高。64 岁以下患者的 30 天死亡率为 6%，65 岁以上患者为 10%。对于后一组患者，I 期和 II 期联合 p 分期的 5 年生存率为 44%，IIIA 期 p 分期为 19%。总之，结果表明，在精确的术前风险 - 效益评估的情况下，老年患者也适合进行支气管癌的手术治疗。
